67
Publications
8.9K
Citations
46
H-Index
1992
Active since
Shailaja Kasibhatla is an author at Genomics Institute of the Novartis Research Foundation specializing in medicine, cell death, and apoptosis.
Top concepts
MedicineCell DeathApoptosisPharmacologyDrug DiscoveryCell BiologyNatural SciencesBiochemistryMedicinal ChemistryCell Signaling
Publications per year
1992–2024
67
67
The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer
Luc Friboulet, Nanxin Li, Ryohei Katayama et al. · Cancer Discovery · 2014 · 820 citations · Full text
Why target apoptosis in cancer treatment?
Shailaja Kasibhatla, Ben Tseng · PubMed · 2003 · 354 citations
Rows per page
1–5 of 67